Gnanasambandan Ramanathan

Prof. Gnanasambandan Ramanathan

Vellore Institute of Technology, Vellore, Vellore, India

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2016 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
GRGnanasambandan Ramanathan
Gnanasambandan Ramanathan
RERamprasad Elumalai
Ramprasad Elumalai
SPSoundararajan Periyasamy
Soundararajan Periyasamy
LBLVKS Bhaskar
LVKS Bhaskar
Autosomal dominant polycystic kidney disease (ADPKD) is a monogenic disorder and is a common genetic cause of chronic renal failure in children and adults. The enzyme renin plays a key role in the RAAS cascade and an important role in the development of hypertension and progression of renal disease in ADPKD. The present study is aimed to investigate the potential modifier effect of REN gene polymorphisms on the progression of chronic kidney disease (CKD) in ADPKD. We analyzed 102 ADPKD patients and 106 healthy controls from the same geographic area. FRET-based KASPar single-nucleotide polymorphism (SNP) genotyping assays for REN gene tag-SNPs (rs2887284, rs2368564, rs1464816, rs7521667, rs10900555, rs6693954, rs6676670 and rs11571078) were performed. Cochran-Armitage trend test was used to assess the potential associations between these polymorphisms and CKD stages. Haplotype frequencies and LD measures were estimated by using the software Haploview. Mantel-Haenszel stratified analysis was used to explore confounding and interaction effects of these polymorphisms. Of the eight tag-SNPs genotyped, the rs10900555 polymorphism deviated from the Hardy-Weinberg equilibrium in controls. The presence of ADPKD in general was not significantly associated with the REN tag-SNPs included in this study. Linkage disequilibrium analysis yielded three haplotype blocks and the haplotypes of the respective blocks are not statistically different between ADPKD and controls. In multivariate analysis, the rs1464816 TG genotype showed a significant association with the advancement of CKD in ADPKD (OR = 4.80; 95 % CI = 1.30–17.82; p = 0.019). The present study provides evidence that the rs1464816 polymorphism in REN is associated with CKD progression in ADPKD.

29 August 2022 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
RTRamkumar Thirunavukarasu
Ramkumar Thirunavukarasu
GCGeorge Priya Doss C
George Priya Doss C
GRGnanasambandan Ramanathan
Gnanasambandan Ramanathan
MGMohanraj Gopikrishnan
Mohanraj Gopikrishnan
VPVenkatesh Palanisamy
Venkatesh Palanisamy

7 September 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Anirban Goutam MukherjeeAnirban Goutam Mukherjee
Anirban Goutam Mukherjee
UWUddesh Ramesh Wanjari
Uddesh Ramesh Wanjari
AAArunraj N A
Arunraj N A
RMReshma Murali
Reshma Murali
Prabakaran D.SPrabakaran D.S
Prabakaran D.S
Abilash Valsala GopalakrishnanAbilash Valsala Gopalakrishnan
Abilash Valsala Gopalakrishnan
Cancer immunotherapy moderates the immune system’s ability to fight cancer. Due to its extreme complexity, scientists are working to put together all the puzzle pieces to get a clearer picture of the immune system. Shreds of available evidence show the connection between cancer and the immune system. Immune responses to tumors and lymphoid malignancies are influenced by B cells, γδT cells, NK cells, and dendritic cells (DCs). Cancer immunotherapy, which encompasses adoptive cancer therapy, monoclonal antibodies (mAbs), immune checkpoint therapy, and CART cells, has revolutionized contemporary cancer treatment. This article reviews recent developments in immune cell regulation and cancer immunotherapy. Various options are available to treat many diseases, particularly cancer, due to the progress in various immunotherapies, such as monoclonal antibodies, recombinant proteins, vaccinations (both preventative and curative), cellular immunotherapies, and cytokines.

6 February 2023
Verified
Book Chapter
Closed access
NINilmani
Nilmani
MDMaria D'Costa
Maria D'Costa
ABAnusha Bothe
Anusha Bothe
SDSoumik Das
Soumik Das
Udhaya Kumar. SUdhaya Kumar. S
Udhaya Kumar. S
George Priya Doss C.George Priya Doss C.
George Priya Doss C.

14 January 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
Anirban Goutam MukherjeeAnirban Goutam Mukherjee
Anirban Goutam Mukherjee
UWUddesh Ramesh Wanjari
Uddesh Ramesh Wanjari
SKSandra Kannampuzha
Sandra Kannampuzha
RMReshma Murali
Reshma Murali
AAArunraj N A
Arunraj N A
Abilash Valsala GopalakrishnanAbilash Valsala Gopalakrishnan
Abilash Valsala Gopalakrishnan
As a complex endocrine and metabolic condition, polycystic ovarian syndrome (PCOS) affects women’s reproductive health. These common symptoms include hirsutism, hyperandrogenism, ovulatory dysfunction, irregular menstruation, and infertility. No one knows what causes it or how to stop it yet. Alterations in gut microbiota composition and disruptions in secondary bile acid production appear to play a causative role in developing PCOS. PCOS pathophysiology and phenotypes are tightly related to both enteric and vaginal bacteria. Patients with PCOS exhibit changed microbiome compositions and decreased microbial diversity. Intestinal microorganisms also alter PCOS patient phenotypes by upregulating or downregulating hormone release, gut-brain mediators, and metabolite synthesis. The human body’s gut microbiota, also known as the “second genome,” can interact with the environment to improve metabolic and immunological function. Inflammation is connected to PCOS and may be caused by dysbiosis in the gut microbiome. This review sheds light on the recently discovered connections between gut microbiota and insulin resistance (IR) and the potential mechanisms of PCOS. This study also describes metabolomic studies to obtain a clear view of PCOS and ways to tackle it.

16 January 2024 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
ABAchsha Babu
Achsha Babu
VRV Devi Rajeswari
V Devi Rajeswari
VGV Ganesh
V Ganesh
SDSoumik Das
Soumik Das
SDSivaraman Dhanasekaran
Sivaraman Dhanasekaran
GRGnanasambandan Ramanathan
Gnanasambandan Ramanathan